当地时间3月17日,莫德纳(Moderna)寻求美国食品药品监督管理局(FDA)授权第四剂新冠疫苗。莫德纳寻求第四剂的覆盖范围为所有18岁以上的成年人,包括那些因年龄或其他疾病感染新冠几率较大,以及医护人员等高风险人群。这一覆盖范围远远超过辉瑞和德国生物技术公司(BioNTech SE)前两天提出的针对65岁及以上人群接种第四剂疫苗的申请。关于有效性,莫德纳并没有给出具体说明,但其表示,提交的部分...
Source Link华尔街见闻2022-03-18
当地时间3月17日,莫德纳(Moderna)寻求美国食品药品监督管理局(FDA)授权第四剂新冠疫苗。莫德纳寻求第四剂的覆盖范围为所有18岁以上的成年人,包括那些因年龄或其他疾病感染新冠几率较大,以及医护人员等高风险人群。这一覆盖范围远远超过辉瑞和德国生物技术公司(BioNTech SE)前两天提出的针对65岁及以上人群接种第四剂疫苗的申请。关于有效性,莫德纳并没有给出具体说明,但其表示,提交的部分...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Terms and Conditions·Privacy Policy
Company: TTMF Limited. Tech supported by Xiangshang Yixin.
Email:uservice@ttm.financial